A Study of Nivolumab in Participants With Locally Advanced or Metastatic (Stage IIIB-IV) Non-Small Cell Lung Cancer (NSCLC) With Squamous and Non-Squamous Histology After Prior Chemotherapy Treated in Real World Settings in Greece and Cyprus
Clinical trial NCT05034926 · COMPLETED
Trial details
- NCT number
- NCT05034926
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-10-07
- Primary completion
- 2025-10-31
- Enrollment
- 212
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.